Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2019 / N 2

Оценка качества жизни больных псориазом: обзор современных исследований
А.Г. Пашинян, А.С. Дворников, Е.В. Донцова

Список литературы

1. What quality of life? The WHOQOL Group. World Health Organization quality of life assessment. World Health Forum 1996;17(4):354-6.
2. Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. СПб., М., 2002. 320 c.
3. 22nd annual conference of the International Society for Quality of Life Research. Quality of Life Research 2015 Oct;24(Suppl 1):1-191.
4. Cieza A, Stucki G. The International Classification of Functioning Disability and Health: its development process and content validity. European Journal of Physical and Rehabilitation Medicine 2008 Sep;44(3):303-13.
5. Соколова Е.Е., Мартынов А.А. Психологические особенности и качество жизни больных псориазом. Клиническая геронтология 2007;13(10):40-3.
6. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health and Quality of Life Outcomes 2006 Jun;4:35.
7. Silva MF, Fortes MR, Miot MD, Marques SA. Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment. Anais Brasileiros de Dermatologia 2013 Sep-Oct;88(5):760-3.
8. Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. Journal of the European Academy of Dermatology and Venereology 2014;28(3):333-7.
9. Якубович А.И., Новицкая Н.Н., Корепанов А.Р. Псориаз и качество жизни. Сибирский журнал дерматологии и венерологии 2009;10(1):34-8.
10. Kelley NL. Living with psoriasis: a patient case study. Journal of Visual Communication in Medicine 2015;38(3-4):164-7.
11. Singh SM, Narang T, Dogra S, Verma AK, Gupta S, Handa S. Psychiatric morbidity in patients with psoriasis. Cutis 2016 Feb;97(2):107-12.
12. Leovigildo ÉS, David RA, Mendes AS. Stress level of people with psoriasis at a public hospital. Anais Brasileiros de Dermatologia 2016 Jul-Aug;91(4):446-54.
13. Korman NJ, Zhao Y, Pike J, Roberts J. Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA. Clinical and Experimental Dermatology 2016 Jul;41(5):514-21.
14. Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One 2012;7(12):e52935.
15. Schmitt J, Küster D. Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis. Archives of Dermatological Research 2015 Jul;307(5):451-3.
16. Basavaraj KH, Navya MA, Rashmi R. Stress and quality of life in psoriasis: an update. International Journal of Dermatology 2011Jul;50(7):783-92.
17. Stucki G, Kostanjsek N, Ustün B, Cieza A. ICF-based classification and measurement of functioning. European Journal of Physical and Rehabilitation Medicine 2008 Sep;44(3):315-28.
18. Rauch A, Cieza A, Stucki G. How to apply the International Classification of Functioning, Disability and Health (ICF) for rehabilitation management in clinical practice. European Journal of Physical and Rehabilitation Medicine 2008 Oct;44(3):329-42.
19. Xhaja A, Shkodrani E, Frangaj S, Kuneshka L, Vasili E. An epidemiological study on trigger factors and quality of life in psoriatic patients. Materia Sociomedica 2014 Jun;26(3):168-71.
20. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety and suicidality in patients with psoriasis: a population-based cohort study. Archives of Dermatology 2010 Aug;146(8):891-5.
21. Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. The Journal of Investigative Dermatology 2014 Jun;134(6):1542-51.
22. Tee SI, Lim ZV, Theng CT, Chan KL, Giam YC. A prospective cross-sectional study of anxiety and depression in patients with psoriasis in Singapore. Journal of the European Academy of Dermatology and Venereology 2016 Jul;30(7):1159-64.
23. Sampogna F, Sera F, Abeni D; IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. The Journal of Investigative Dermatology 2004 Mar;122(3):602-7.
24. Bouguéon K, Misery L. Depression and psoriasis. Annales de Dermatologie et Vénéréologie 2008 Feb;135(4):254-8.
25. Cohen BE, Martires KJ, Ho RS. Psoriasis and the risk of depression in the US population: National Health and Nutrition Examination Survey 2009-2012. JAMA Dermatology 2016 Jan;152(1):73-9.
26. Hrehorów E, Salomon J, Matusiak L, Reich A, Szepietowski JC. Patients with psoriasis feel stigmatized. Acta Dermato-Venereologica 2012 Jan;92(1):67-72.
27. Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: a Danish Nationwide study. Acta Dermato-Venereologica 2016 Feb;96(2):218-21.
28. Duvetorp A, Østergaard M, Skov L, Seifert O, Tveit KS, Danielsen K, Iversen L. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP). Archives of Dermatological Research 2019 Jul;311(5):351-60.
29. Chamoun A, Goudetsidis L, Poot F, Bourdeaud’hui F, Titeca G. Psoriasis and depression. Revue Médicale de Bruxelles 2015;36(1):23-8.
30. Филонова А.В., Утц С.Р., Шнайдер Д.А., Гуськова О.П. Психокоррекционные мероприятия в комплексной терапии больных псориазом. Саратовский научно-медицинский журнал 2015;11(3):466-71.
31. Дороженок И.Ю., Пушкарев Д.Ф. Психические расстройства, обусловленные стрессогенным влиянием псориаза. Психические расстройства в общей медицине 2010;3:16-20.
32. Петрова Н.Н., Смирнова И.О., Лихонос Л.М. Сравнительная оценка различных подходов к терапии больных псориазом. Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева 2013;1:63-70.

References

1. What quality of life? The WHOQOL Group. World Health Organization quality of life assessment. World Health Forum 1996;17(4):354-6.
2. Novik AA, Ionova TI. Guide to the study of life quality in medicine. Saint Petersburg, Moscow, 2002. 320 p. (In Russian).
3. 22nd annual conference of the International Society for Quality of Life Research. Quality of Life Research 2015 Oct;24(Suppl 1):1-191.
4. Cieza A, Stucki G. The International Classification of Functioning Disability and Health: its development process and content validity. European Journal of Physical and Rehabilitation Medicine 2008 Sep;44(3):303-13.
5. Sokolova EE, Martynov AA. Psychological features and quality of life in patients with psoriasis. Clinical Gerontology 2007;13(10):40-3 (In Russian).
6. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health and Quality of Life Outcomes 2006 Jun;4:35.
7. Silva MF, Fortes MR, Miot MD, Marques SA. Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment. Anais Brasileiros de Dermatologia 2013 Sep-Oct;88(5):760-3.
8. Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. Journal of the European Academy of Dermatology and Venereology 2014;28(3):333-7.
9. Yakubovich AI, Novitskaya NN, Korepanov AR. Psoriasis and quality of life. Siberian Journal of Dermatology & Venereology 2009;10(1):34-8 (In Russian).
10. Kelley NL. Living with psoriasis: a patient case study. Journal of Visual Communication in Medicine 2015;38(3-4):164-7.
11. Singh SM, Narang T, Dogra S, Verma AK, Gupta S, Handa S. Psychiatric morbidity in patients with psoriasis. Cutis 2016 Feb;97(2):107-12.
12. Leovigildo ÉS, David RA, Mendes AS. Stress level of people with psoriasis at a public hospital. Anais Brasileiros de Dermatologia 2016 Jul-Aug;91(4):446-54.
13. Korman NJ, Zhao Y, Pike J, Roberts J. Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA. Clinical and Experimental Dermatology 2016 Jul;41(5):514-21.
14. Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One 2012;7(12):e52935.
15. Schmitt J, Küster D. Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis. Archives of Dermatological Research 2015 Jul;307(5):451-3.
16. Basavaraj KH, Navya MA, Rashmi R. Stress and quality of life in psoriasis: an update. International Journal of Dermatology 2011Jul;50(7):783-92.
17. Stucki G, Kostanjsek N, Ustün B, Cieza A. ICF-based classification and measurement of functioning. European Journal of Physical and Rehabilitation Medicine 2008 Sep;44(3):315-28.
18. Rauch A, Cieza A, Stucki G. How to apply the International Classification of Functioning, Disability and Health (ICF) for rehabilitation management in clinical practice. European Journal of Physical and Rehabilitation Medicine 2008 Oct;44(3):329-42.
19. Xhaja A, Shkodrani E, Frangaj S, Kuneshka L, Vasili E. An epidemiological study on trigger factors and quality of life in psoriatic patients. Materia Sociomedica 2014 Jun;26(3):168-71.
20. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety and suicidality in patients with psoriasis: a population-based cohort study. Archives of Dermatology 2010 Aug;146(8):891-5.
21. Dowlatshahi EA, Wakkee M, Arends LR, Nijsten T. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. The Journal of Investigative Dermatology 2014 Jun;134(6):1542-51.
22. Tee SI, Lim ZV, Theng CT, Chan KL, Giam YC. A prospective cross-sectional study of anxiety and depression in patients with psoriasis in Singapore. Journal of the European Academy of Dermatology and Venereology 2016 Jul;30(7):1159-64.
23. Sampogna F, Sera F, Abeni D; IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. The Journal of Investigative Dermatology 2004 Mar;122(3):602-7.
24. Bouguéon K, Misery L. Depression and psoriasis. Annales de Dermatologie et Vénéréologie 2008 Feb;135(4):254-8.
25. Cohen BE, Martires KJ, Ho RS. Psoriasis and the risk of depression in the US population: National Health and Nutrition Examination Survey 2009-2012. JAMA Dermatology 2016 Jan;152(1):73-9.
26. Hrehorów E, Salomon J, Matusiak L, Reich A, Szepietowski JC. Patients with psoriasis feel stigmatized. Acta Dermato-Venereologica 2012 Jan;92(1):67-72.
27. Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: a Danish Nationwide study. Acta Dermato-Venereologica 2016 Feb;96(2):218-21.
28. Duvetorp A, Østergaard M, Skov L, Seifert O, Tveit KS, Danielsen K, Iversen L. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP). Archives of Dermatological Research 2019 Jul;311(5):351-60.
29. Chamoun A, Goudetsidis L, Poot F, Bourdeaud'hui F, Titeca G. Psoriasis and depression. Revue Médicale de Bruxelles 2015;36(1):23-8.
30. Filonova AV, Utts SR, Schneider DA, Guskova OP. Psycho-corrective activities in complex therapy of patients with psoriasis. Saratov Journal of Medical Scientific Research 2015;11(3):466-71 (In Russian).
31. Dorozhenok IYu, Pushkarev DF. Mental disorders caused by psoriasis stress effect. Mental Disorders in General Medicine 2010;3:16-20 (In Russian).
32. Petrova NN, Smirnova IO, Likhonos LM. Comparative evaluation of different approaches to therapy in patients with psoriasis. VM Bekhterev Review of Psychiatry and Medical Psychology 2013;1:63-70 (In Russian).
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]